EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Palmitoylation-related ACSM3 suppresses ovarian cancer progression via interacting with HSPD1 and regulating lipid metabolism

Qin Ling, Huishan Xu, Yuying Chen, Siqi Yang, Hao Tan, Zuwei Zhang, Tingting Sun, Jihui Kang, Huiling Lai, Jinglan Chen, Linxiang Wu, Guofen Yang

Cellular Oncology · 30.10.2026

DOI: 10.1007/s13402-026-01318-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 30.10.2026. Verfasst von Qin Ling und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ling, Q., Xu, H., Chen, Y., Yang, S., Tan, H., Zhang, Z., Sun, T., Kang, J., Lai, H., Chen, J., Wu, L., & Yang, G. (2026). Palmitoylation-related ACSM3 suppresses ovarian cancer progression via interacting with HSPD1 and regulating lipid metabolism. Cellular Oncology. https://doi.org/10.1007/s13402-026-01318-y

Vancouver

Ling Q, Xu H, Chen Y, Yang S, Tan H, Zhang Z, et al. Palmitoylation-related ACSM3 suppresses ovarian cancer progression via interacting with HSPD1 and regulating lipid metabolism. Cellular Oncology. 2026. doi:10.1007/s13402-026-01318-y

BibTeX
@article{Ling2026,
  author = {Ling, Qin and Xu, Huishan and Chen, Yuying and Yang, Siqi and Tan, Hao and Zhang, Zuwei and Sun, Tingting and Kang, Jihui and Lai, Huiling and Chen, Jinglan and Wu, Linxiang and Yang, Guofen},
  title = {Palmitoylation-related ACSM3 suppresses ovarian cancer progression via interacting with HSPD1 and regulating lipid metabolism},
  journal = {Cellular Oncology},
  year = {2026},
  doi = {10.1007/s13402-026-01318-y}
}
Kostenlos starten →